Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06088277 · ClinicalTrials.gov registry record · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
A NA study of HIV Infections, sponsored by Boston University.
- Recruiting
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 2
- Study locations
NCT06088277 is a NA study of HIV Infections that is actively recruiting participants, run by Boston University. The registered enrollment target is 266 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06088277, a NA study of HIV Infections, is actively recruiting participants, sponsored by Boston University.
- RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.
Conditions Studied
Interventions
- BEHAVIORAL TM HIV
- BEHAVIORAL TM HL
Study Locations (2)
Massachusetts
- South End Community Health Center - Boston
- East Boston Neighborhood Health Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2027-04-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06088277
The ClinicalTrials.gov registry entry for NCT06088277 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 266 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (40% lower). The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which TM HIV is the first listed.
NCT06088277 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06088277 about?
NCT06088277 is a clinical study titled "Texting to Reduce Human Immunodeficiency Virus (HIV) Risk". This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participant...
What is the current status of trial NCT06088277?
This trial is currently recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2024-08-16. Estimated completion is 2027-04-14.
What conditions does trial NCT06088277 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06088277?
The interventions under investigation include: TM HIV (BEHAVIORAL), TM HL (BEHAVIORAL).
Who is sponsoring clinical trial NCT06088277?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06088277 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.